153 related articles for article (PubMed ID: 18348878)
1. Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment.
Soubrane G
Surv Ophthalmol; 2008; 53(2):121-38. PubMed ID: 18348878
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularisation in pathological myopia: an update in management.
Chan WM; Ohji M; Lai TY; Liu DT; Tano Y; Lam DS
Br J Ophthalmol; 2005 Nov; 89(11):1522-8. PubMed ID: 16234465
[TBL] [Abstract][Full Text] [Related]
3. Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation.
Weber ML; Heier JS
Dev Ophthalmol; 2016; 55():167-75. PubMed ID: 26501802
[TBL] [Abstract][Full Text] [Related]
4. Choroidal neovascularization in pathological myopia.
Neelam K; Cheung CM; Ohno-Matsui K; Lai TY; Wong TY
Prog Retin Eye Res; 2012 Sep; 31(5):495-525. PubMed ID: 22569156
[TBL] [Abstract][Full Text] [Related]
5. Vision loss in younger patients: a review of choroidal neovascularization.
Miller DG; Singerman LJ
Optom Vis Sci; 2006 May; 83(5):316-25. PubMed ID: 16699445
[TBL] [Abstract][Full Text] [Related]
6. Fundus autofluorescence in subfoveal choroidal neovascularisation secondary to Pathological Myopia.
Parodi MB; Iacono P; Ravalico G
Br J Ophthalmol; 2009 Jun; 93(6):771-4. PubMed ID: 19336427
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia.
Chan NS; Teo K; Cheung CM
Eye Contact Lens; 2016 Jan; 42(1):48-55. PubMed ID: 26448447
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia.
Lai TY; Chan WM; Liu DT; Lam DS
Retina; 2009 Jun; 29(6):750-6. PubMed ID: 19357555
[TBL] [Abstract][Full Text] [Related]
9. Myopic maculopathy: a review.
Silva R
Ophthalmologica; 2012; 228(4):197-213. PubMed ID: 22846778
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor: the future treatment of choroidal neovascularization in pathologic myopia?
Zhu H; Wang FH; Sun XD
Chin Med J (Engl); 2013; 126(8):1578-83. PubMed ID: 23595398
[No Abstract] [Full Text] [Related]
11. Lacquer crack formation and choroidal neovascularization in pathologic myopia.
Ikuno Y; Sayanagi K; Soga K; Sawa M; Gomi F; Tsujikawa M; Tano Y
Retina; 2008 Oct; 28(8):1124-31. PubMed ID: 18779719
[TBL] [Abstract][Full Text] [Related]
12. [Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization--cases report].
Figurska M; Stankiewicz A
Klin Oczna; 2008; 110(10-12):387-91. PubMed ID: 19195173
[TBL] [Abstract][Full Text] [Related]
13. Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia.
Yan M; Huang Z; Lian HY; Song YP; Chen X
Acta Ophthalmol; 2019 Aug; 97(5):e813-e814. PubMed ID: 30187680
[No Abstract] [Full Text] [Related]
14. Recent trends in the management of maculopathy secondary to pathological myopia.
Mitry D; Zambarakji H
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):3-13. PubMed ID: 22159713
[TBL] [Abstract][Full Text] [Related]
15. Why acute decreased vision in patients with high myopia is an emergency?
Chaimae H; Daoudi R
Pan Afr Med J; 2014; 19():281. PubMed ID: 25870736
[No Abstract] [Full Text] [Related]
16. Choroidal neovascularization after LASIK in a patient with low myopia.
Bailey CS
J Cataract Refract Surg; 2006 Jan; 32(1):4. PubMed ID: 16516763
[No Abstract] [Full Text] [Related]
17. Choroidal neovascularization after LASIK in a patient with low myopia.
Bailey CS
J Cataract Refract Surg; 2005 Nov; 31(11):2041-2. PubMed ID: 16412900
[No Abstract] [Full Text] [Related]
18. Natural history of choroidal neovascularization in high myopia.
Miller DG; Singerman LJ
Curr Opin Ophthalmol; 2001 Jun; 12(3):222-4. PubMed ID: 11389351
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
Maguire MG; Alexander J; Fine SL;
Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
